|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03880 MEDTIDE
Nominal 
22.740 +1.040 (+4.793%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | -- | -- | 442,226 | 336,774 | 350,840 |
| Cost of Sales | -- | -- | (192,452) | (156,603) | (149,771) |
| Gross Profit | -- | -- | 249,774 | 180,171 | 201,069 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (84,308) | (45,971) | (68,190) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | 78,449 | 61,978 | 67,556 | |
| Taxation | -- | -- | (19,276) | (13,073) | (13,576) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 217,371 | 267.348% | 59,173 | 48,905 | 53,980 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | (12,419) | (6,696) | 367 |
| Depreciation & Amortisation | -- | -- | 30,089 | 29,781 | 25,933 |
| Directors' Emoluments | -- | -- | 13,335 | 3,857 | 4,304 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 163.000 | 246.809% | 47.000 | 39.000 | 54.000 |
| DPS (cts) | 0.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.964 | 0.707 | 1.342 |
| NBV per share ($) | -- | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 217,371 |
| %Change | 267.348% |
| EPS / (LPS) | RMB 1.630 |
| NBV Per Share (¥) | RMB -- |